CoChat

Pros and cons of pragmatic clinical trials

Lurie, Jon D, Morgan, Tamara S · 2013 · Journal of Comparative Effectiveness Research
Cited by 57

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Traditional randomized controlled trials are the ‘gold standard’ for evaluating health interventions and are typically designed to maximize internal validity, often at the cost of limited generalizability. Pragmatic randomized controlled trials should be designed with a conscious effort to generate evidence with a greater external validity by making the research question as similar as possible to the questions faced by clinical decision-makers (i.e., patients and their families, physicians, policy makers and administrators) and then answer that question with rigor. Clarity and transparency about the specifics of the research question are the keys to designing, as well as interpreting, any clinical trial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2217/cer.12.74

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 16

  1. Thomas Pynchon. Gravity’s Rainbow . Viking Press Inc. NY USA (1973).
  2. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J. Clin. Epidemiol. 62(5), 499–505 (2009). · DOI · Paper page
  3. Sackett DL. Explanatory and pragmatic clinical trials: a primer and application to a recent asthma trial. Pol. Arch. Med. Wewn. 121(7–8), 259–263 (2011). · DOI
  4. Godwin M, Ruhland L, Casson I et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med. Res. Methodol. 3, 28 (2003). · DOI · Paper page
  5. Thorpe KE, Zwarenstein M, Oxman AD et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J. Clin. Epidemiol. 62(5), 464–475 (2009). · DOI · Paper page
  6. Karanicolas PJ, Montori VM, Devereaux PJ, Schunemann H, Guyatt GH. A new ‘mechanistic-practical’ framework for designing and interpreting randomized trials. J. Clin. Epidemiol. 62(5), 479–484 (2009). · DOI
  7. Mohr P, Bitter I, Constant E et al. Myth and reality of pragmatic trials. Psychiatr. Danub. 22(1), 2–3 (2010).
  8. Kent DM, Kitsios G. Against pragmatism: on efficacy, effectiveness and the real world. Trials 10, 40 (2009). · DOI · Paper page
  9. Riddle DL, Johnson RE, Jensen MP et al. The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team. J. Clin. Epidemiol. 63(11), 1271–1275 (2010). · DOI
  10. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J. Chronic Dis. 20(8), 637–648 (1967). · DOI · Paper page
  11. Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 10, 37 (2009). · DOI · Paper page
  12. March J, Kraemer HC, Trivedi M et al. What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology 35(13), 2491–2501 (2010). · DOI
  13. Schulz KF. Subverting randomization in controlled trials. JAMA 274(18), 1456–1458 (1995). · DOI · Paper page
  14. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325(7), 445–453 (1991). · DOI · Paper page
  15. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 279(16), 1278–1281 (1998). · DOI · Paper page
  16. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290(12), 1624–1632 (2003). · DOI

Cited by

Metadata

Authors
Lurie, J. D., & Morgan, T. S.
Venue
Journal of Comparative Effectiveness Research
Published
2013-01
Volume
2
Issue
1
Pages
53-58
ISSN
  • 2042-6305 (ISSN-L)
  • 2042-6313
OpenAlex
W2109993319
Cited by
57
References
5
FWCI
3.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.